Senior Accountant, Freenome
$106.3-165k
Biological analysis platform for cancer
Job no longer available
Biological analysis platform for cancer
501-1000 employees
Job no longer available
$106.3-165k
501-1000 employees
Company mission
To create tools that empower everyone to prevent, detect, and treat their disease.
Role
Who you are
- Bachelor's degree in Accounting
- At least 5 years of accounting experience, including at least 2 years of audit experience
- NetSuite experience required
- Strong proficiency in MS Excel
- Strong communication skills and ability to communicate in a team environment
- Excellent time management and organization skills
- Strong attention to detail with strong analytical and problem-solving skills
- Able to work independently with minimal supervision
- Ability to manage multiple tasks and competing priorities
What the job involves
- Assist in quarterly and year-end audits, including gathering support documentation and partnering with the audit team
- Partner with cross-functional teams to track, maintain, and post clinical trial accruals
- Process accurate and timely payroll and employee benefit journal entries
- Assist in establishing compliance related to Sarbanes-Oxley (SOX)
- Participate in close activities, including preparing journal entries, financial statements, and reconciliations, while ensuring transactions are recorded timely and accurately
- Manage monthly stock-based compensation and post journal entries
- Maintain and update accounting policies and procedures in accordance with GAAP
- Perform ad-hoc projects as required
Our take
Freenome is a biotechnology company offering a biological analysis platform that uses molecular biology and machine learning to detect cancer with a routine blood draw. The platform trains on thousands of cancer-positive blood samples to recognise disease-associated patterns and help detect early-stage cancer, allowing clinicians to optimise treatments.
The company specialises in advanced computational biology, using machine learning to detect patterns among billions of circulating cell-free biomarkers. Freenome continues to focus on the development of its colorectal cancer test, potentially helping the 45 million people not currently up-to-date on colorectal cancer screening guidelines in the United States.
Following its 2022 funding round, the company surpassed the $1 billion funding mark. Freenome is set to accelerate the development of its platform, testing for additional cancers and furthering its blood test detection technology. It's also forming partnerships for R&D purposes, joining forces with health firms such as Geisinger to provide real-world data that could help it detect multiple cancers.
Steph
Company Specialist at Welcome to the Jungle
Insights
14% employee growth in 12 months
Company
Funding (last 2 of 8 rounds)
Nov 2025
$75m
LATE VC
Feb 2024
$254m
LATE VC
Total funding: $1.1bn
Company HQ
The East Side, South San Francisco, CA
Leadership
Riley Ennis
(Co-Founder)Studied at Yale, Johns Hopkins and Dartmouth. Was a Thiel Fellow and co-founded Immudicon and Oncolinx.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 13 more jobs at Freenome